Extended Interval Dosing with Ocrelizumab in Multiple Sclerosis
MULTIPLE SCLEROSIS JOURNAL(2024)
关键词
Multiple sclerosis,anti-CD20,ocrelizumab,treatment interval,NEDA-3,biomarkers,neuroimaging,personalized medicine,extended dosing
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要